<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">transmed</journal-id><journal-title-group><journal-title xml:lang="ru">Трансляционная медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Translational Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-4495</issn><issn pub-type="epub">2410-5155</issn><publisher><publisher-name>Almazov National Medical Research Centre, Saint Petersburg, Russia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/2311-4495-2024-11-5-419-427</article-id><article-id custom-type="edn" pub-id-type="custom">DIRGLY</article-id><article-id custom-type="elpub" pub-id-type="custom">transmed-994</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МОЛЕКУЛЯРНАЯ БИОЛОГИЯ И ГЕНЕТИКА</subject></subj-group></article-categories><title-group><article-title>Влияние полиморфизма rs1800629 гена TNFα на показатели цитокинового профиля при осложненном течении раневого процесса у пострадавших с боевой травмой</article-title><trans-title-group xml:lang="en"><trans-title>The effect of the TNFα gene rs1800629 polymorphism on cytokine profile parameters in the complicated wound healing in combat trauma victims</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кишеня</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kishenya</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кишеня Мария Сергеевна, к.м.н., доцент, старший научный сотрудник Центральной научно-исследовательской лаборатории</p><p>пр. Ильича, 16, Донецк, 283003</p></bio><bio xml:lang="en"><p>Maria S. Kishenya, MD, PhD, Associate Professor, Senior researcher at the Central Research Laboratory</p><p>Ilyich ave., 16, Donetsk, 283003</p></bio><email xlink:type="simple">maria.kishenya@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соболев</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sobolev</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Соболев Дмитрий Васильевич, д.м.н., профессор, профессор кафедры комбустиологии и пластической хирургии факультета интернатуры и последипломного образования</p><p>Донецк</p></bio><bio xml:lang="en"><p>Dmitrii V. Sobolev, MD, PhD, Doctor of Medical Sciences, Professor, Professor of the Department of Combustiology and Plastic Surgery of the Faculty of Internship and Postgraduate Education</p><p>Donetsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Анчикова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Anchikova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анчикова Екатерина Васильевна, врач-дерматовенеролог</p><p>Красногорск</p></bio><bio xml:lang="en"><p>Ekaterina V. Anchikova, dermatovenerologist</p><p>Krasnogorsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Висягин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Visyagin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Висягин Артур Вячеславович, старший лаборант кафедры комбустиологии и пластической хирургии факультета интернатуры и последипломного образования</p><p>Донецк</p></bio><bio xml:lang="en"><p>Artur V. Visyagin, Senior laboratory assistant of the Department of Combustiology and Plastic Surgery of the Faculty of Internship and Postgraduate Education</p><p>Donetsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Донецкий государственный медицинский университет имени М. Горького» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Donetsk State Medical University named after M. Gorky</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Общество с ограниченной ответственностью «МедВитро»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>MedVitro Limited Liability Company</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>10</day><month>11</month><year>2024</year></pub-date><volume>11</volume><issue>5</issue><fpage>419</fpage><lpage>427</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кишеня М.С., Соболев Д.В., Анчикова Е.В., Висягин А.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Кишеня М.С., Соболев Д.В., Анчикова Е.В., Висягин А.В.</copyright-holder><copyright-holder xml:lang="en">Kishenya M.S., Sobolev D.V., Anchikova E.V., Visyagin A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://transmed.almazovcentre.ru/jour/article/view/994">https://transmed.almazovcentre.ru/jour/article/view/994</self-uri><abstract><p>Актуальность. При раневом процессе существует высокая вероятность развития осложнений в виде паратравматической экземы (ПТЭ), что определяет тяжесть раневой репарации. Генетические факторы, ответственные за синтез и регуляцию иммунорегуляторных цитокинов, играют ведущую роль в этиопатогенезе ПТЭ. Цель исследования: определить связь полиморфизма rs1800629 гена TNFα с развитием ПТЭ и цитокинами IL-1β, TNFα и IL-6. Материалы и методы. В исследование были включены 162 пациента после оперативных вмешательств по поводу боевых ранений, которые составили 2 группы: I группа — 82 человека с осложнениями в виде ПТЭ и II — 80 человек без осложнений, в контрольную группу включены 30 практически здоровых человек. Исследование rs1800629 гена TNFα проводили с помощью метода полимеразной цепной реакции. В плазме крови определяли содержание цитокинов TNFα, IL-1β и IL-6 методом иммуноферментного анализа. Результаты. Установлена связь ПТЭ с вариантами генотипов и аллелей rs1800629 гена TNFα (р = 0,033 и р = 0,005). На увеличение шансов развития ПТЭ оказывали влияние генотипы GА (ОШ = 1,64; 95 % ДИ 0,83–3,24) и АА (ОШ = 2,94; 95 % ДИ 0,9–9,67), аллель А (ОШ = 2,13; 95 % ДИ 1,26–3,6) rs1800629. Во II группе показатели IL-1β, TNFα и IL-6 значимо превышали контрольные значения (р &lt; 0,001) с преобладанием у носителей АА генотипа rs1800629. Выводы. Полиморфизм rs1800629 гена TNFα ассоциирован с развитием ПТЭ. Увеличение содержания IL-1β, TNFα и IL-6 было связано с наличием патогенетического фактора — генотипа АА rs1800629 гена TNFα в развитии осложнений.</p></abstract><trans-abstract xml:lang="en"><p>Background. In the wound process, there is a high probability of complications in the form paratraumatic eczema (РТЕ), which determines the severity the course of wound repair. Genetic factors responsible for the regulation of cytokines a leading role in the etiopathogenesis of РТЕ. Aim — determine the relationship of TNFa gene rs1800629 with the development of РТЕ and IL-1ß, TNFα, IL-6. Materials and methods. The study included 162 patients after surgical interventions. Group I — 82 people with complications in the form PTE and II — 80 people without complications. The study rs1800629 TNFα gene was carried out by the poly- merase chain reaction method. The levels TNFα, IL-1β and IL-6 in the blood was determined by the enzyme immunoassay method. Results. A connection with PTE was established with of rs1800629 gene TNFα (p = 0.033 and p = 0.005). The genotypes GA (OR = 1.64; CI 0.83–3.24) and AA (OR = 2.94; CI 0.9–9.67), allele A (OR = 2.13; CI 1.26–3.6) rs1800629 influenced the increased chances of developing PTE. In group II the IL- 1β, TNFα, IL-6 indicators were increased (p &lt; 0.001) in carriers of the AA genotype rs1800629. Conclusion. rs1800629 TNFα gene is associated with development of PTE. An increase in the levels IL-1β, TNFα, IL-6 was associated with the presence of a pathogenetic factor — AA genotype rs1800629 TNFα gene in development of complications.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>паратравматическая экзема</kwd><kwd>цитокины</kwd><kwd>rs1800629</kwd><kwd>TNFα.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cytokines</kwd><kwd>paratraumatic eczema</kwd><kwd>rs1800629</kwd><kwd>TNFα</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Schindler M, Drozdenko G, Kuhl AA, Worm M. Immunomodulation in patients with chronic hand eczema treated with oral alitretinoin. Int Arch Allergy Immunol. 2014;165:18–26. doi.org/10.1159/000365659.</mixed-citation><mixed-citation xml:lang="en">Schindler M, Drozdenko G, Kuhl AA, Worm M. Immunomodulation in patients with chronic hand eczema treated with oral alitretinoin. Int Arch Allergy Immunol. 2014;165:18–26. doi.org/10.1159/000365659.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Heede NG, Thyssen JP, Thuesen BH, et al. Health- related quality of life in adult dermatitis patients stratifiedby filaggrin genotype. Contact Dermatitis. 2017;76(3):167–77. DOI: 10.1111/cod.12731.</mixed-citation><mixed-citation xml:lang="en">Heede NG, Thyssen JP, Thuesen BH, et al. Health- related quality of life in adult dermatitis patients stratifiedby filaggrin genotype. Contact Dermatitis. 2017;76(3):167–77. DOI: 10.1111/cod.12731.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lan CC, Tu НР, Wu С, et al. Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing population. Exp Dermatol. 2011;20(12):975–9. DOI: 10.1111/j.1600-0625.2011.01374.x.</mixed-citation><mixed-citation xml:lang="en">Lan CC, Tu НР, Wu С, et al. Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing population. Exp Dermatol. 2011;20(12):975–9. DOI: 10.1111/j.1600-0625.2011.01374.x.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Visser MJ, Landeck L, Campbell LE, et al. Impact of atopic dermatitis and loss‐of‐function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis. Br J Dermatol. 2013;168(2):326–32. DOI: 10.1111/bjd.12083.</mixed-citation><mixed-citation xml:lang="en">Visser MJ, Landeck L, Campbell LE, et al. Impact of atopic dermatitis and loss‐of‐function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis. Br J Dermatol. 2013;168(2):326–32. DOI: 10.1111/bjd.12083.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Guzik TJ, Cosentino F. Epigenetics and Immunometabolism in Diabetes and Aging. Antioxid Redox Signal. 2017;11:72–99. DOI: 10.1089/ars.2017.7299.</mixed-citation><mixed-citation xml:lang="en">Guzik TJ, Cosentino F. Epigenetics and Immunometabolism in Diabetes and Aging. Antioxid Redox Signal. 2017;11:72–99. DOI: 10.1089/ars.2017.7299.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kaiser J, Archana J, Javeed А. TNF-alpha −308G/ A and −238G/A polymorphisms and its protein network associated with type 2 diabetes mellitus. Saudi J Biol Sci. 2017;24(6):1195–1203. DOI: 10.1016/j.sjbs.2016.05.012.</mixed-citation><mixed-citation xml:lang="en">Kaiser J, Archana J, Javeed А. TNF-alpha −308G/ A and −238G/A polymorphisms and its protein network associated with type 2 diabetes mellitus. Saudi J Biol Sci. 2017;24(6):1195–1203. DOI: 10.1016/j.sjbs.2016.05.012.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lampropoulou I.-Th, Stangou М, Papagianni А. TNF-α and Microalbuminuria in Patients with Type 2 Diabetes Mellitus. J Diabetes Res. 2014;2014:394206. DOI: 10.1155/2014/394206.</mixed-citation><mixed-citation xml:lang="en">Lampropoulou I.-Th, Stangou М, Papagianni А. TNF-α and Microalbuminuria in Patients with Type 2 Diabetes Mellitus. J Diabetes Res. 2014;2014:394206. DOI: 10.1155/2014/394206.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhuang L, Ma W, Cai D, et al. Associations between tumor necrosis factor-alpha polymorphisms and risk of psoriasis: a meta-analysis. PLoS One. 2013;8(12):e68827. doi.org/10.1371/journal.pone.0068827.</mixed-citation><mixed-citation xml:lang="en">Zhuang L, Ma W, Cai D, et al. Associations between tumor necrosis factor-alpha polymorphisms and risk of psoriasis: a meta-analysis. PLoS One. 2013;8(12):e68827. doi.org/10.1371/journal.pone.0068827.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">European convention for the protection of vertebrate animal used for experimental and other scientific purposes. Council of Europe, Strasbourg. 1986:53.</mixed-citation><mixed-citation xml:lang="en">European convention for the protection of vertebrate animal used for experimental and other scientific purposes. Council of Europe, Strasbourg. 1986:53.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Landeck L. Impact of tumour necrosis factor-α polymorphisms on irritant contact dermatitis. Contact Dermatitis. 2012;66(4):221–7. DOI: 10.1111/j.1600-0536.2011.02045.x.</mixed-citation><mixed-citation xml:lang="en">Landeck L. Impact of tumour necrosis factor-α polymorphisms on irritant contact dermatitis. Contact Dermatitis. 2012;66(4):221–7. DOI: 10.1111/j.1600-0536.2011.02045.x.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Agodi A, Barchitta M, Valenti G, et al. Role of the TNFα -308G&gt;A polymorphism in the genetic susceptibility to acne vulgaris in a sicilian population. Ann Ig. 2012;24(5):351–7.</mixed-citation><mixed-citation xml:lang="en">Agodi A, Barchitta M, Valenti G, et al. Role of the TNFα -308G&gt;A polymorphism in the genetic susceptibility to acne vulgaris in a sicilian population. Ann Ig. 2012;24(5):351–7.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lee HY, Stieger M, Yawalkar N, Kakeda M. Cytokines and chemokines in irritant contact dermatitis. Mediators of inflammation. 2013; 2013:916497. doi.org/10.1155/2013/916497.</mixed-citation><mixed-citation xml:lang="en">Lee HY, Stieger M, Yawalkar N, Kakeda M. Cytokines and chemokines in irritant contact dermatitis. Mediators of inflammation. 2013; 2013:916497. doi.org/10.1155/2013/916497.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Davis JA, Visscher MO, Wickett RR, Hoath SB. Influence of tumour necrosis factor-α polymorphism-308 and atopy on irritant contact dermatitis in healthcare workers. Contact Dermatitis. 2010;63(6):320–32. DOI: 10.1111/j.1600-0536.2010.01778.x.</mixed-citation><mixed-citation xml:lang="en">Davis JA, Visscher MO, Wickett RR, Hoath SB. Influence of tumour necrosis factor-α polymorphism-308 and atopy on irritant contact dermatitis in healthcare workers. Contact Dermatitis. 2010;63(6):320–32. DOI: 10.1111/j.1600-0536.2010.01778.x.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Бабаджанов О.А., Арифов С.С. Роль гена TNF-α в формировании розацеа. Медицинские новости. 2020;3:73–75.</mixed-citation><mixed-citation xml:lang="en">Babadzhanov OA, Arifov SS. Rol’ gena TNF-α v formirovanii rosacea. Medicinskie novosti. 2020;3:73–5. In Russian</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
